Role of Jak3 in chronic myeloid leukemia: Evidence to identify Jak3 as a potential therapeutic target

被引：0
|
作者：
Lin, Q
Prudkin, ML
Kantarjian, HM
Cortes, JE
Lau, E
Grammatikakis, I
Thomazy, VA
Lai, R
Amin, HM
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Alberta, Lab Med & Pathol, Edmonton, AB, Canada
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2870
引用
收藏
页码：804A / 805A
页数：2
相关论文
共 50 条
  • [1] JAK3 Variants in Adults with Myeloid Malignancies and Potential for Response to JAK3 Inhibition
    Assi, Rita
    Benton, Christopher B.
    Al Rawi, Ahmed
    Chamoun, Kamal
    Wang, Feng
    Pierce, Sherry
    Patel, Keyur P.
    Hamilton, Betty K.
    DiNardo, Courtney D.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Kadia, Tapan
    Verstovsek, Srdan
    Andreeff, Michael
    BLOOD, 2017, 130
  • [2] MUTATION OF JAK3 IN A PATIENT WITH SCID - ESSENTIAL ROLE OF JAK3 IN LYMPHOID DEVELOPMENT
    RUSSELL, SM
    TAYEBI, N
    NAKAJIMA, H
    RIEDY, MC
    ROBERTS, JL
    AMAN, MJ
    MIGONE, TS
    NOGUCHI, M
    MARKERT, ML
    BUCKLEY, RH
    O'SHEA, JJ
    LEONARD, WJ
    SCIENCE, 1995, 270 (5237) : 797 - 800
  • [3] Therapeutic potential of Janus kinase 3 (JAK3) inhibitors
    Cetkovic-Cyrlje, M
    Tibbles, HE
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (15) : 1767 - 1784
  • [4] IDENTIFICATION OF SOMATIC JAK3 MUTATIONS IN ACUTE MYELOID LEUKEMIA
    Riera, L.
    Bonello, L.
    Sismondi, F.
    Tondat, F.
    Marmont, F.
    Godio, L.
    di Cell, P. Francia
    Chiarle, R.
    Inghirami, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 407 - 407
  • [5] IDENTIFICATION OF SOMATIC JAK3 MUTATIONS IN ACUTE MYELOID LEUKEMIA
    Riera, L.
    Bonello, L.
    Sismondi, F.
    Tondat, F.
    Marmont, F.
    Godio, L.
    di Celle, Francia P.
    Chiarle, R.
    Inghirami, G.
    HAEMATOLOGICA, 2008, 93 : S24 - S24
  • [6] Role of JAK3 in myogenic differentiation
    Jang, You-Na
    Lee, Il Jae
    Park, Myong Chul
    Baik, Eun Joo
    CELLULAR SIGNALLING, 2012, 24 (03) : 742 - 749
  • [7] Activation of the Jak3 pathway and myeloid differentiation
    Mangan, JK
    Reddy, EP
    LEUKEMIA & LYMPHOMA, 2005, 46 (01) : 21 - 27
  • [8] Design of JAK3 covalent inhibitors for the interrogation of JAK3 signaling in humans
    Casimiro-Garcia, Agustin
    Thorarensen, Atli
    Telliez, Jean-Baptiste
    Balbo, Paul
    Banker, Mary
    Brown, Matthew
    Che, Ye
    Chrencik, Jill
    Coe, Jotham
    Czerwinski, Robert
    Dowty, Martin
    Gilbert, Adam
    Hayward, Matthew
    Hegen, Martin
    Juba, Brian
    Jussif, Jason
    Langille, Jonathan
    Leung, Louis
    Liang, Sidney
    Lin, Tsung
    Montgomery, Justin
    Soucy, Sarah
    Trujillo, John
    Unwalla, Ray
    Vajdos, Felix
    Vincent, Fabien
    Yang, Xin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [9] JAK3 inhibition: what potential for the future?
    Legendre, Christophe
    TRANSPLANTATION RESEARCH, 2013, 2
  • [10] Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL
    Degryse, Sandrine
    Bornschein, Simon
    de Bock, Charles E.
    Leroy, Emilie
    Vanden Bempt, Marlies
    Demeyer, Sofie
    Jacobs, Kris
    Geerdens, Ellen
    Gielen, Olga
    Soulier, Jean
    Harrison, Christine J.
    Constantinescu, Stefan N.
    Cools, Jan
    BLOOD, 2018, 131 (04) : 421 - 425
12345